| MeSH term | MeSH ID | Detail |
|---|---|---|
| Hyperlipidemias | D006949 | 73 associated lipids |
| Malabsorption Syndromes | D008286 | 16 associated lipids |
| Albuminuria | D000419 | 18 associated lipids |
| Vasculitis | D014657 | 14 associated lipids |
| Atherosclerosis | D050197 | 85 associated lipids |
| Peripheral Arterial Disease | D058729 | 7 associated lipids |
| Thromboangiitis Obliterans | D013919 | 4 associated lipids |
| Bird Diseases | D001715 | 4 associated lipids |
| Obesity, Morbid | D009767 | 8 associated lipids |
| Cell Transformation, Viral | D002472 | 26 associated lipids |
lauric acid
lauric acid is a lipid of Fatty Acyls (FA) class. Lauric acid is associated with abnormalities such as Infection, Renal tubular disorder, Hypertensive disease, Obesity and Mycoses. The involved functions are known as Transcription, Genetic, Signal Transduction, Mutation, metaplastic cell transformation and Anabolism. Lauric acid often locates in Skin, Plasma membrane, Cytoplasmic matrix, Body tissue and Palmar surface. The associated genes with lauric acid are Gene Family, SLC33A1 gene, Homologous Gene, Open Reading Frames and P4HTM gene. The related lipids are Fatty Acids, Oleic Acids, Palmitates, Stearates and 9,11-linoleic acid.
Cross Reference
Introduction
To understand associated biological information of lauric acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with lauric acid?
lauric acid is suspected in Renal tubular disorder, Hypertensive disease, Infection, Renal vascular disorder, Obesity, Mycoses and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with lauric acid
PubChem Associated disorders and diseases
What pathways are associated with lauric acid
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with lauric acid?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with lauric acid?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with lauric acid?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with lauric acid?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with lauric acid?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with lauric acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Hara H et al. | Effect of (+/-)-2-(dimethylamino)-1-[[o-(m-methoxyphenethyl)phenoxy] methyl]ethyl hydrogen succinate on experimental models of peripheral obstructive disease. | 1991 | Arzneimittelforschung | pmid:1930349 |
| Idris CA and Sundram K | Effect of dietary cholesterol, trans and saturated fatty acids on serum lipoproteins in non-human primates. | 2002 | Asia Pac J Clin Nutr | pmid:12492627 |
| Serra I et al. | Effect of dietary intake on the levels of biliary unsaturated free Fatty acids having inhibitory activity on mutagens. | 2009 | Asian Pac. J. Cancer Prev. | pmid:20104986 |
| Hanley K et al. | Development of a plant viral-vector-based gene expression assay for the screening of yeast cytochrome p450 monooxygenases. | 2003 | Assay Drug Dev Technol | pmid:15090141 |
| HÃ¥versen L et al. | Induction of proinflammatory cytokines by long-chain saturated fatty acids in human macrophages. | 2009 | Atherosclerosis | pmid:18599066 |
| Yoshida H et al. | A phosphodiesterase 3 inhibitor, K-134, improves hindlimb skeletal muscle circulation in rat models of peripheral arterial disease. | 2012 | Atherosclerosis | pmid:22269153 |
| Arrol S et al. | The effects of fatty acids on apolipoprotein B secretion by human hepatoma cells (HEP G2). | 2000 | Atherosclerosis | pmid:10856517 |
| Redgrave TG and Dunne KB | Chylomicron formation and composition in unanaesthetised rabbits. | 1975 Nov-Dec | Atherosclerosis | pmid:173354 |
| Lagrost L et al. | Variations in serum cholesteryl ester transfer and phospholipid transfer activities in healthy women and men consuming diets enriched in lauric, palmitic or oleic acids. | 1999 | Atherosclerosis | pmid:10030391 |
| Timbermont L et al. | Control of Clostridium perfringens-induced necrotic enteritis in broilers by target-released butyric acid, fatty acids and essential oils. | 2010 | Avian Pathol. | pmid:20390546 |
| Alves NF et al. | Acute Treatment with Lauric Acid Reduces Blood Pressure and Oxidative Stress in Spontaneously Hypertensive Rats. | 2017 | Basic Clin. Pharmacol. Toxicol. | pmid:28054477 |
| Stark K et al. | Expression of CYP4F12 in gastrointestinal and urogenital epithelia. | 2004 | Basic Clin. Pharmacol. Toxicol. | pmid:15078342 |
| Russell VA et al. | Animal models of attention-deficit hyperactivity disorder. | 2005 | Behav Brain Funct | pmid:16022733 |
| Hu H et al. | A novel class of antagonists for the FFAs receptor GPR40. | 2009 | Biochem. Biophys. Res. Commun. | pmid:19818732 |
| Bambal RB and Hanzlik RP | Active site structure and substrate specificity of cytochrome P450 4A1: steric control of ligand approach perpendicular to heme plane. | 1996 | Biochem. Biophys. Res. Commun. | pmid:8605007 |
| Leighton F et al. | Peroxisomal fatty acid oxidation is selectively inhibited by phenothiazines in isolated hepatocytes. | 1984 | Biochem. Biophys. Res. Commun. | pmid:6732769 |
| Okita R and Chance C | Induction of laurate omega-hydroxylase by di (2-ethylhexyl)phthalate in rat liver microsomes. | 1984 | Biochem. Biophys. Res. Commun. | pmid:6732809 |
| Han S et al. | Structural insights into the binding of lauric acid to CYP107L2 from Streptomyces avermitilis. | 2017 | Biochem. Biophys. Res. Commun. | pmid:27890614 |
| Kiffel L et al. | Purification and characterization of a cytochrome P-450 isozyme isolated from the liver of rats pretreated with clofibrate. | 1988 | Biochem. Biophys. Res. Commun. | pmid:3140811 |
| Murakami K et al. | Evidence for direct binding of fatty acids and eicosanoids to human peroxisome proliferators-activated receptor alpha. | 1999 | Biochem. Biophys. Res. Commun. | pmid:10403814 |